EP0227110A2 — Human immunoglobulin G FC region protein and production thereof
Assigned to Teijin Ltd · Expires 1987-07-01 · 39y expired
What this patent protects
A monomeric human immunoglobulin G Fc region protein having 224 amino acid residues and a dimer thereof; gene fragment coding for the protein; plasmids containing the gene fragment; microorganisms transformed with the plasmid; and a process for production of the above mentioned h…
USPTO Abstract
A monomeric human immunoglobulin G Fc region protein having 224 amino acid residues and a dimer thereof; gene fragment coding for the protein; plasmids containing the gene fragment; microorganisms transformed with the plasmid; and a process for production of the above mentioned human immunoglobulin G Fc region protein comprising culturing the transformed microorganism and recovering the protein from the culture.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.